We are proud to announce that we have been selected as one of the 120 most promising deep tech companies in the European Union to
We are pleased to announce that we have received a grant from the Recovery and Resilience plan of 3 million EUR. It is intended for
Prostate cancer represents growing burden on healthcare systems – direct costs related to its treatment and diagnostics in Slovakia grew by more than 2.5 times
We have accepted an invitation from Slovak television TA3 to discuss prostate cancer, which is one of the most common oncological diseases among men in
We are very pleased that Innovate Slovakia has included us to the list of the most promising and innovative startups to watch in 2024. Success
On Saturday May 25th our team of runners joined forces at the event “Run for Healthy Breasts“, aimed to support the fight against breast cancer
Read the interview we gave to the daily newspaper SME on the topic of early diagnosis of cancer. We are very grateful for all the
Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a
It is a great pleasure for us to introduce our Head of Regulatory and Clinical Affairs, who joined Glycanostics in February this year. Zuzana Batova
